[The microbial degradation of the 1,4-oxathiin derivative, 2,3-dihydro-5-carboxanilido-6-methyl-1,4-oxathiin (DCMO)].
D000083:Acetanilides / Q000378:metabolism*; D000813:Anilides / Q000096:biosynthesis; D000935:Antifungal Agents / Q000378:metabolism*; D002087:Butyrates / Q000096:biosynthesis; D055598:Chemical Phenomena; D002621:Chemistry; D002855:Chromatography, Thin Layer; D006571:Heterocyclic Compounds / Q000378:metabolism*; D007259:Infrared Rays; D012233:Rhizopus / Q000378:metabolism*; D012988:Soil Microbiology; D013057:Spectrum Analysis; D014466:Ultraviolet Rays
D000083:Acetanilides; D000813:Anilides; D000935:Antifungal Agents; D002087:Butyrates; D006571:Heterocyclic Compounds
Der mikrobielle Abbau des 1,4-Oxathiinderivats, 2,3-Dihydro-5-carboxamilido-6-methyl-1,4-oxathiin (DCMO)